
Inclusion and exclusion criteria for the immunotherapy combined with quad-shot radiotherapy study protocol.

Head and neck squamous-cell carcinoma
ONCOLOGY, ADVERSE EVENT, ADVERSE EVENT
ALT: Alanine transaminase; ANC: Absolute neutrophil count; A/R/M: Advanced, recurrent or metastatic; AST: Aspartate aminotransferase; CTCAE: Common Terminology Criteria for Adverse Events; ECOG: Eastern Cooperative Oncology Group; HNSCC: Head and neck squamous-cell carcinoma; irAE: Immune-related adverse event; IRB: Institutional review board; QS: Quad-shot; QTc: QT interval corrected for heart rate; RT: Radiotherapy; ULN: Upper limit of normal.